A second phase III study, to evaluate long-acting cabotegravir for the prevention of HIV infection in young women.
Phase of Trial: Phase III
Latest Information Update: 28 Dec 2016
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 28 Dec 2016 New trial record
- 20 Dec 2016 According to ViiV Healthcare media release, company plans to initiate this trial in 2017.